Philipp Oster

3.3k total citations
57 papers, 2.7k citations indexed

About

Philipp Oster is a scholar working on Epidemiology, Microbiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philipp Oster has authored 57 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 56 papers in Microbiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philipp Oster's work include Bacterial Infections and Vaccines (56 papers), Pneumonia and Respiratory Infections (53 papers) and Influenza Virus Research Studies (15 papers). Philipp Oster is often cited by papers focused on Bacterial Infections and Vaccines (56 papers), Pneumonia and Respiratory Infections (53 papers) and Influenza Virus Research Studies (15 papers). Philipp Oster collaborates with scholars based in New Zealand, Italy and Norway. Philipp Oster's co-authors include Jane O’Hallahan, Diana Martin, Einar Rosenqvist, Diana Lennon, Ellen Ypma, Johan Holst, Richard Arnold, Ingeborg S. Aaberge, Ray Borrow and Jamie Findlow and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Philipp Oster

54 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipp Oster New Zealand 29 2.4k 2.3k 265 229 221 57 2.7k
Jamie Findlow United Kingdom 36 3.2k 1.4× 3.2k 1.4× 332 1.3× 221 1.0× 234 1.1× 93 3.6k
Daniela Toneatto Italy 25 2.0k 0.8× 2.0k 0.9× 244 0.9× 162 0.7× 181 0.8× 50 2.4k
Stefania Bambini Italy 20 1.7k 0.7× 1.5k 0.7× 211 0.8× 307 1.3× 182 0.8× 27 1.9k
Keith Cartwright United Kingdom 26 2.0k 0.8× 2.1k 1.0× 216 0.8× 176 0.8× 166 0.8× 46 2.5k
Daniela Hozbor Argentina 26 1.5k 0.6× 1.3k 0.6× 169 0.6× 374 1.6× 108 0.5× 90 2.0k
Jane O’Hallahan New Zealand 19 1.3k 0.5× 1.2k 0.5× 152 0.6× 154 0.7× 117 0.5× 24 1.5k
G Bjune Norway 19 1.6k 0.7× 1.5k 0.7× 240 0.9× 136 0.6× 137 0.6× 29 1.9k
Jo Anne Welsch United States 24 1.8k 0.7× 1.6k 0.7× 443 1.7× 270 1.2× 173 0.8× 37 2.1k
Porter Anderson United States 29 1.7k 0.7× 2.4k 1.1× 659 2.5× 480 2.1× 245 1.1× 48 3.4k
Maurizio Comanducci Italy 35 2.7k 1.1× 2.3k 1.0× 744 2.8× 581 2.5× 240 1.1× 45 3.6k

Countries citing papers authored by Philipp Oster

Since Specialization
Citations

This map shows the geographic impact of Philipp Oster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Oster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Oster more than expected).

Fields of papers citing papers by Philipp Oster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Oster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Oster. The network helps show where Philipp Oster may publish in the future.

Co-authorship network of co-authors of Philipp Oster

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Oster. A scholar is included among the top collaborators of Philipp Oster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Oster. Philipp Oster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Robertson, Corwin A., et al.. (2023). Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study. Human Vaccines & Immunotherapeutics. 19(1). 2160600–2160600. 8 indexed citations
3.
Dubey, Himanshu, et al.. (2022). Risk Factors for Contracting Invasive Meningococcal Disease and Related Mortality: A Systematic Literature Review and Meta-analysis. International Journal of Infectious Diseases. 119. 1–9. 6 indexed citations
4.
Evans, Keith E., et al.. (2022). Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health. 22(1). 380–380. 20 indexed citations
5.
Martinón‐Torres, Federico, et al.. (2021). A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Review of Vaccines. 20(9). 1123–1146. 8 indexed citations
6.
Choi, Heun, Hyukmin Lee, Jun Hyoung Kim, et al.. (2021). Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea. PLoS ONE. 16(1). e0244716–e0244716. 5 indexed citations
7.
8.
9.
10.
Lennon, Diana, Sui H. Wong, Jing Yan, et al.. (2011). Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers. Archives of Disease in Childhood. 96(8). 744–751. 21 indexed citations
11.
Findlow, Jamie, Ray Borrow, Matthew D. Snape, et al.. (2010). Multicenter, Open‐Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy. Clinical Infectious Diseases. 51(10). 1127–1137. 226 indexed citations
12.
Snape, Matthew D., Tom Dawson, Philipp Oster, et al.. (2010). Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life. The Pediatric Infectious Disease Journal. 29(11). e71–e79. 159 indexed citations
13.
Elias, Johannes, Leo M. Schouls, Ingrid van de Pol, et al.. (2010). Vaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany. Emerging infectious diseases. 16(3). 464–472. 19 indexed citations
14.
Lennon, Diana, Catherine Jackson, Joanna Stewart, et al.. (2009). Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine. The Pediatric Infectious Disease Journal. 28(5). 385–390. 28 indexed citations
15.
Horton, Rachel, Christopher Hobbs, Jamie Findlow, et al.. (2008). Mucosal Immunity in Healthy Adults after Parenteral Vaccination with Outer‐Membrane Vesicles fromNeisseria meningitidisSerogroup B. The Journal of Infectious Diseases. 198(5). 731–740. 28 indexed citations
16.
Jackson, Claire, Diana Lennon, Jing Yan, et al.. (2008). Phase II meningococcal B vesicle vaccine trial in New Zealand infants. Archives of Disease in Childhood. 94(10). 745–751. 21 indexed citations
17.
Lennon, Diana, Kumanan Rasanathan, Jane O’Hallahan, et al.. (2005). Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: Beginning of epidemic control. Vaccine. 24(9). 1395–1400. 58 indexed citations
18.
19.
O’Hallahan, Jane, Diana Lennon, Philipp Oster, et al.. (2005). From secondary prevention to primary prevention: a unique strategy that gives hope to a country ravaged by meningococcal disease. Vaccine. 23(17-18). 2197–2201. 38 indexed citations
20.
McVernon, Jodie, Jenny MacLennan, Jim Buttery, et al.. (2002). Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children. The Pediatric Infectious Disease Journal. 21(8). 747–753. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie Findlow Breakdown of academic impact, for papers by Daniela Toneatto Breakdown of academic impact, for papers by Stefania Bambini Breakdown of academic impact, for papers by Keith Cartwright Breakdown of academic impact, for papers by Daniela Hozbor Breakdown of academic impact, for papers by Jane O’Hallahan Breakdown of academic impact, for papers by G Bjune Breakdown of academic impact, for papers by Jo Anne Welsch Breakdown of academic impact, for papers by Porter Anderson Breakdown of academic impact, for papers by Maurizio Comanducci
Rankless by CCL
2026